Page last updated: 2024-12-05

2,6-diaminopyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,6-Diaminopyridine is a versatile organic compound with various applications. It is typically synthesized through the nitration of pyridine followed by reduction of the nitro groups. 2,6-Diaminopyridine serves as a crucial building block in the synthesis of numerous pharmaceuticals, agrochemicals, and polymers. Its two amino groups enable diverse reactions, making it a valuable reagent for the development of new compounds. 2,6-Diaminopyridine has been explored for its potential in treating various diseases due to its ability to interact with biological targets. Research focuses on its effects on enzymes, receptors, and other biomolecules. Further research is ongoing to investigate its therapeutic potential and to optimize its synthesis and application.'

2,6-diaminopyridine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8861
CHEMBL ID339234
SCHEMBL ID64599
MeSH IDM0492337

Synonyms (69)

Synonym
BIDD:GT0354
2,6-diamino pyridine
nsc1921
wln: t6nj bz fz
141-86-6
nsc-1921
brn 0108513
dap (amine)
nsc 1921
ccris 6682
ai3-18054
einecs 205-507-2
26D ,
pyridine-2,6-diamine
inchi=1/c5h7n3/c6-4-2-1-3-5(7)8-4/h1-3h,(h4,6,7,8
2,6-pyridinediamine
pyridine, 2,6-diamino-
pyridine-2,6-diyldiamine
2,6-diaminopyridine
2,6-diaminopyridine, 98%
AC-907/25014391
D1154
AC-10706
CHEMBL339234
AKOS000119875
NCGC00249093-01
tox21_303403
dtxsid0040127 ,
cas-141-86-6
NCGC00257467-01
dtxcid8020127
tox21_201654
NCGC00259203-01
BBL011548
pyridin2,6-diaminopyridinee-2,6-diamine
STL146681
k89ab8ckg6 ,
unii-k89ab8ckg6
5-22-11-00255 (beilstein handbook reference)
FT-0610533
AM20070129
rodol 26pyr
diaminopyridine [vandf]
2,6-diaminopyridine [inci]
diaminopyridine, 2,6-
SCHEMBL64599
2,6-diamino-pyridine
2, 6-diaminopyridine
2,6-diaminopyrdine
Q-200205
STR00979
PS-9269
118352-40-2
mfcd00006329
CS-W020019
F8881-0498
D77864
2,6-diaminopyridine, vetec(tm) reagent grade, 98%
118352-39-9
6-amino-2-iminopyridine
2,6-diaminopyridine 100 microg/ml in acetonitrile
BCP27453
Q15725608
26-dap
2-pyridinamine,1,6-dihydro-6-imino-,(z)-(9ci)
2-pyridinamine,1,6-dihydro-6-imino-,(e)-(9ci)
EN300-21301
HY-Y0198
Z104495224
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency2.34970.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency34.27910.000221.22318,912.5098AID1259243; AID1259381; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency13.68540.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency48.27270.001022.650876.6163AID1224838; AID1224893
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency9.77120.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency30.42710.003041.611522,387.1992AID1159552; AID1159555
aryl hydrocarbon receptorHomo sapiens (human)Potency57.64670.000723.06741,258.9301AID743085; AID743122
thyroid stimulating hormone receptorHomo sapiens (human)Potency61.42360.001628.015177.1139AID1224843; AID1224895; AID1259385
Histone H2A.xCricetulus griseus (Chinese hamster)Potency112.07090.039147.5451146.8240AID1224845
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency34.08110.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1311190Binding affinity to 5'-Biotinylated DNA d(CTG)9-3' (unknown origin) assessed as red shifting of abosrption band at 349 nm at 10 uM by UV-spectrophotometric analysis2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Synthesis of 1H-pyrrolo[3,2-h]quinoline-8-amine derivatives that target CTG trinucleotide repeats.
AID16352Dissociation constant (pKa)1980Journal of medicinal chemistry, Apr, Volume: 23, Issue:4
2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 3. C-Benzylation of aminopyridines with phenolic Mannich bases. Synthesis of 1- and 3-deaza analogues of trimethoprim.
AID1593346Binding affinity to full-length human CDK2 expressed in Escherichia coli BL21 (DE3) pLysS cells at 1 to 5 mM by isothermal titration calorimetry2019Journal of medicinal chemistry, 04-11, Volume: 62, Issue:7
FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.45)18.7374
1990's0 (0.00)18.2507
2000's6 (19.35)29.6817
2010's22 (70.97)24.3611
2020's1 (3.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.26 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index45.89 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]